Analysis of changes in age of initiation of illicit drug use in Australia
Research shows that earlier initiation of drug use is associated with a range of adverse outcomes later in life including problematic substance use patterns, the use of other illicit drugs, engaging in risk behaviours, greater involvement in criminal activity and completion of fewer years of education.
The National Drug Strategy Household Survey (NDSHS) is a representative population sample of Australians that asks about illicit drug use. Analyses of the 1998 NDSHS data found that more recent age cohorts (i.e. younger Australians) were significantly more likely to have initiated a range of drugs (including cannabis, amphetamines, heroin and LSD) by 15 years of age and they had a lower mean age of first drug use compared to their older counterparts. The study also found increased recent use of illicit drugs among the younger birth cohorts.
There have been many changes in illicit drug markets in Australia since the late 1990s including increasing prevalence of amphetamine and methamphetamine use and declines in cannabis use across all age cohorts, but most dramatically among the younger birth cohorts.
This project is open to students
Update data and monitor trends
The objective is to update analysis of NDSHS survey data over time (2001 to 2022) to monitor trends in age of initiation and prevalence of illicit drug use by birth cohort over time among Australians.
Open to
- Honours
- Masters by research
Supervisors
More student projects
View 61 more
The Gist: a pornography education program to improve sexual health and wellbeing in young people
The Gist helps young people navigate sex and relationships. It includes a website, educational videos and in-person education sessions in schools and youth services in Victoria.
Bridging the gap in pre-eclampsia research through evidence surveillance
Accelerating Innovation for Mothers (AIM) 2.0
Globally, approximately 287,000 women die every year from pregnancy-related conditions and complications, with most of these deaths occurring in low- and middle-income countries (LMICs). Although investment in global maternal health has increased in the past 30 years, research and development (R&D) of new products has been a neglected area.
Project contacts
Student supervisor contacts
Professor Paul Dietze
Co-Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
Project team
Dr Amanda Roxburgh
Senior Research Fellow
Professor Paul Dietze
Co-Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
Why study at Burnet?
When you study at Burnet, you broaden your impact working across our three Institute-wide programs: Disease Elimination; Health Security and Pandemic Preparedness; Maternal, Child and Adolescent Health.
Train with internationally recognised experts in a structured student support system, and gain a holistic research experience along the way.